Abstract
This thesis states that there are not only science-related, but also non-sciencerelated, institutional barriers to the translation of personalized medicine (PM) into clinical practice. Its primary research subject is to identify and evaluate policy levers to reduce existing institutional barriers in order to foster the translation of personalized medicine into clinical practice – applied to the Swiss healthcare system.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2018 Springer Fachmedien Wiesbaden GmbH, part of Springer Nature
About this chapter
Cite this chapter
Bosshard, K. (2018). Final conclusion. In: Law and Economics of Personalized Medicine. Gesundheitsmanagement und Gesundheitsökonomik. Springer Gabler, Wiesbaden. https://doi.org/10.1007/978-3-658-22074-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-658-22074-7_7
Published:
Publisher Name: Springer Gabler, Wiesbaden
Print ISBN: 978-3-658-22073-0
Online ISBN: 978-3-658-22074-7
eBook Packages: Economics and FinanceEconomics and Finance (R0)